US administration will set targets to slash drug prices

US administration will set targets to slash drug prices

What’s happened?On May 12th US president Donald Trump issued an executive order (EO) announcing plans to drastically lower prescription drug prices in the country. The order kickstarts negotiations that aim to force pharmaceutical companies to cut their US prices to match those charged in other developed countries, on a “most-favoured nation” basis. While the EO relies on negotiations, backed by threats, rather than regulations to achieve its ob…

Media Briefing: Drug Supply Chain, Tariffs, and the Impact on U.S. Prices and Availability

The Johns Hopkins Bloomberg School of Public Health will host an expert media briefing to explore the state of the U.S. pharmaceutical supply chain; proposed tariffs on imported drugs; and the implications for drug prices, availability, and domestic production. The U.S. prescription drug supply depends heavily on a complex global web of suppliers. Recent policy proposals introducing tariffs on imported pharmaceuticals raise questions about affor…